Related Experiment Video
Updated: Sep 17, 2025

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
[Early Predictors for Hypertriglyceridemic Acute Pancreatitis].
Wenting Peng1, Kaiwei Li1, Yuhao Song1
1( 610041) Department of Cardiology, West China Hospital, Sichuan University, Chengdu 610041, China.
Hypertriglyceridemic acute pancreatitis (HTG-AP) is increasing. This review explores predictive factors for HTG-AP, aiming to improve early detection and personalized treatment strategies for better patient outcomes.
Area of Science:
- Gastroenterology and Hepatology
- Endocrinology
- Biochemistry
Background:
- Hypertriglyceridemic acute pancreatitis (HTG-AP) incidence is rising, with high triglycerides linked to increased severity and complications.
- Risk factors for HTG-AP require systematic exploration for effective clinical management.
- Early identification and management of HTG-AP are crucial to prevent recurrence.
Purpose of the Study:
- To systematically review and identify predictive factors for hypertriglyceridemic acute pancreatitis (HTG-AP).
- To provide clinicians with early warning signals for HTG-AP risk.
- To aid in developing personalized treatment protocols and risk prediction models for HTG-AP.
Main Methods:
- Literature review focusing on etiology and pathogenesis of HTG-AP.
- Analysis of relevant biomarkers, including C-reactive protein, Ca2+, PT, and D-dimer.
- Synthesis of findings to identify predictive factors for HTG-AP.
Main Results:
- High triglyceride levels are a significant factor in acute pancreatitis severity.
- Specific biomarkers (C-reactive protein, Ca2+, PT, D-dimer) show potential in predicting HTG-AP.
- Understanding etiological and pathogenetic factors aids in risk assessment.
Conclusions:
- Identifying predictive factors for HTG-AP is essential for clinical practice.
- Early warning signals derived from biomarkers can guide personalized treatment.
- Improved risk prediction models are needed for better management of HTG-AP.
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid Digestion

